One tablet goes to work in seconds to relieve heartburn all day or all night
PITTSBURGH, April 8 /PRNewswire/ -- Approximately 60 million Americans experience heartburn at least once a month. For those sufferers whose occasional heartburn gets in the way of life, TUMS(R), the best selling antacid in America, is introducing a new, long-lasting treatment. TUMS Dual Action, just like all TUMS, goes to work in seconds but also lasts for hours -- all day or all night -- offering heartburn sufferers long-lasting relief without compromise.
TUMS Dual Action contains calcium carbonate, the same trusted ingredient as the regular TUMS that Americans have depended upon for the past 75 years. TUMS Dual Action also includes an additional antacid ingredient, magnesium hydroxide, and 10 mg of famotidine, a safe and effective acid reducer, to help keep heartburn from coming back, making it the longest lasting TUMS ever. Available in Berry or Mint flavor, the one-dose chewable tablet immediately neutralizes acid on contact. Like all TUMS, it is also an excellent source of calcium, with 320 mg of elemental calcium per tablet.
"TUMS Dual Action is a natural extension for the iconic TUMS brand, offering a proven solution for occasional heartburn sufferers looking for long-lasting relief from a trusted source," says Jack Levy, TUMS Brand Manager at GlaxoSmithKline Consumer Healthcare. "With it, heartburn sufferers won't need to think about whether or not lunchtime heartburn will interrupt dinner, or whether they'll be able to sleep without being bothered by heartburn."
A Perfect Partner when Heartburn Breaks Through
In addition to providing relief to occasional heartburn sufferers, TUMS Dual Action can also help patients who experience breakthrough heartburn while taking other medications like proton pump inhibitors (PPIs). Despite high compliance with PPIs, the group of prescription heartburn drugs that reduce stomach acid production, 46% or more of PPI users experience breakthrough heartburn, or episodes of heartburn between doses, often at night. TUMS Dual Action can safely be taken to provide relief from breakthrough heartburn when used as directed.
TUMS Dual Action is currently available nationwide at drug, grocery and mass merchandise stores in both Berry and Mint flavors. The expected retail price for a 25-dose bottle is $8.99, and a 50-dose bottle is $15.49. Through May 15, consumers also have the opportunity to play an instant-win trivia game at www.tumsdualaction.com. The virtual multiple-choice quiz asks consumers general questions about heartburn-inducing foods, and gives participants the opportunity to win one of 400 instant-win "dinner and a movie" prizes consisting of a $25 gift card for Movie Cash or Fandango and a $25 gift card to Brinker Restaurants (Chili's Grill & Bar, Romano's Macaroni Grill, On the Border Mexican Grill & Cantina or Maggiano's Little Italy). All players will be entered into a sweepstakes to win a grand prize weekend getaway to San Francisco, Chicago or New York.
For more information, to download a $3 TUMS Dual Action coupon and for official sweepstakes rules, please visit www.tumsdualaction.com.
For more than 75 years, TUMS(R) has been a fast, effective treatment for heartburn and acid indigestion, neutralizing stomach acid on contact. Today, TUMS is the number one antacid in America, used by more people than any other brand to treat heartburn.
About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare products companies. Its more than 30 well-known brands include the leading smoking cessation products, Nicorette(R) and NicoDerm(R), as well as many medicine cabinet staples, alli(R), Aquafresh(R), Sensodyne(R) and TUMS(R), which are trademarks owned by and/or licensed to GlaxoSmithKline Group of Companies.
GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
|SOURCE GlaxoSmithKline Consumer Healthcare|
Copyright©2009 PR Newswire.
All rights reserved